Newsroom

• Media

Feb 25, 2020

Biomica has been recognized by IVC Research Center and Grove Ventures, as a Next-Gen Deep Tech startup in the Israeli healthcare ecosystem, together with other innovative startups

The results demonstrate the efficacy of Biomica’s live bacterial consortia, BMC426 and BMC427, for the treatment of IBS

Read More

• Media

Oct 23, 2019

Biomica will develop a product based on revelations from Nobel Prize Laureate Prof. Ada Yonath

Read More

• Media

Oct 23, 2019

Biomica and Weizmann Institute to develop a selective drug for resistant bacteria

Read More

• Media

Oct 23, 2019

Biomica will partner with the Weizmann Institute to develop a selective drug for resistant bacteria

Read More

• Media

Oct 23, 2019

Biomica and Weizmann Institute to develop a selective drug for resistant bacteria

Read More

• Media

Apr 16, 2019

Biomica has begun preclinical trials of bacterial-based drugs to treat cancer

Read More

• Media

May 3, 2018

Dr. Elran Haber, CEO of Biomica speaking at ILTV Studio about the Israeli Biomedical company that has just revealed what could be the answer to antibiotic-resistance.

Read More

• Media

Apr 30, 2018

Evogene returns with a startup in the human microbiome

Read More

• Media

Apr 25, 2018

An Israeli company is developing a a microbiome therapy that can help treat diseases. Is this the next big medical innovation?

Read More